Oncology & Cancer

Cost burden of disease progression high in multiple myeloma

(HealthDay)—The economic burden of disease progression is considerable among multiple myeloma (MM) patients receiving drug therapy across all lines of therapy (LOTs), according to a study published online Aug. 7 in Leukemia ...

Medications

Cost of epilepsy meds continues to soar

Costs for epilepsy medications in the United States are skyrocketing, outpacing inflation and straining federal insurers Medicare and Medicaid, according to new research.

Medications

Mining data for the history of pharmaceutical development

(Medical Xpress)—Yale's Michael Kinch spent his spare time in the last year creating a massive database that encompasses the entire history of drug development in the United States. In a series of 20 articles scheduled ...

Medications

'Orphan drug' loophole needs closing, researchers say

Health experts at Johns Hopkins Medicine are calling on lawmakers and regulators to close loopholes in the Orphan Drug Act they claim give drug companies millions of dollars in unintended and misplaced subsidies and tax breaks ...

Medications

Doctors at heart of US opioid crisis

When 55-year-old Sheila Bartels left her doctor's office in Oklahoma, she had a prescription for 510 painkillers.

page 37 from 40